Cardiac Implants
Boston Scientific touts 1st Watchman implantations
UPDATE: Boston Scientific jumps on Watchman approval
Investors sent shares of Boston Scientific (NYSE:BSX) up nearly 4% today after the medical device company said the FDA approved its long-delayed Watchman anti-stroke device.
ACC 2015: St. Jude Medical’s CardioMEMS HF lowers mortality, hospitalizations
FDA approves Boston Scientific’s Watchman anti-stroke device
Medtronic touts real-world study of Reveal Linq heart monitor
SynCardia wins FDA nod for destination therapy trial
SynCardia plans to test its artificial heart as a permanent implant rather than a placeholder for donor transplants in 19 patients. The Arizona company said it won the FDA’s approval to move ahead with the clinical study of its temporary Total Artificial Heart as a permanent transplant option. This is a big advance forward for […]